Company profile

Ticker
TENX
Exchange
CEO
Anthony A. DiTonno
Employees
Incorporated in
Location
Fiscal year end
Former names
Oxygen Biotherapeutics, Inc., Synthetic Blood International Inc
SEC CIK
IRS number
262593535

TENX stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

14 Nov 19
15 Dec 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue
Net income 2.22M 1.76M 1.62M -18.74M
Diluted EPS -0.33 -0.28 -0.33 -5.86
Operating income 2.26M 1.82M 1.66M -11.56M
Net change in cash -1.76M -1.91M -2.05M 9.02M
Cash on hand 6.65M 8.41M 10.32M 12.37M
Cost of revenue
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 0
Net income -14.14M -8.84M -43.92M
Diluted EPS -9.04 -6.27 -31.24
Operating income -6.89M -9.21M -52.65M
Net change in cash 2.87M -12.4M -16.3M
Cash on hand 12.37M 9.5M 21.9M 38.2M
Cost of revenue 0

Financial data from company earnings reports

Financial report summary

?
Competition
Cytokinetics
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg